Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with …

Since COVID‐19 took a strong hold around the globe causing considerable morbidity and
mortality, a lot of effort was dedicated to manufacturing effective vaccines against SARS …

Background A new syndrome of vaccine-induced immune thrombotic thrombocytopenia
(VITT) has emerged as a rare side-effect of vaccination against COVID-19. Cerebral venous …

Introduction This study aims to provide a risk assessment of the adverse reactions related to
the COVID-19 vaccines manufactured by AstraZeneca, Janssen, Moderna, and Pfizer …

The rollout of COVID-19 vaccines brings hope for successful pandemic mitigation and
getting the transmission of SARS-CoV-2 under control. The vaccines authorized in Europe …

Background and Objectives There is accumulating evidence supporting an association
between the thrombosis and thrombocytopenia syndrome (TTS) and adenovirus vector …

Background: To describe cases of retinal vascular events shortly after administration of
mRNA or adenoviral-vectored COVID-19 vaccines. Design: Retrospective, multicenter case …

Despite their proven efficacy and huge contribution to the health of humankind, vaccines
continue to be a source of concern for some individuals around the world. Vaccinations …

Worldwide vaccination against SARS-CoV-2 has allowed the detection of hematologic
autoimmune complications. Adverse events (AEs) of this nature had been previously …

1.1 Background Since March 2021, cases of thromboses associated with thrombocytopenia
have been reported in patients vaccinated with the Oxford-AstraZeneca ChAdOx1-S and …